Skip to main content

How Will We Treat Asthma in the Year 2000?

Buy Article:

$39.50 plus tax (Refund Policy)

Expansion of the understanding of the mechanism of asthma progressed dramatically in the past decade. With this new information, therapeutic emphasis switched from primarily bronchodilator therapy to anti-inflammatory therapy. Concurrently, drugs with different delivery systems as well as higher dose agents were released, simplifying therapy for many patients. The result is a fairly dramatic reexamination of traditionally used medications and attempts to develop newer medications aimed at reducing asthma based on the newer proposed pathophysiological mechanisms. Future management of asthma likely will involve some newer medications as well as the education of the patient and his/her family concerning the behavior of asthma and appropriate steps to take when there is loss of usual asthma control.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Data/Media
No Metrics

Document Type: Research Article

Publication date: 1991-01-01

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more